title: Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patient.
authors.forename: Eirini
authors.initials: E
authors.lastname: Kouroupi
authors.forename: Bruno
authors.initials: B
authors.lastname: Cassinat
authors.forename: Marie-Helene
authors.initials: MH
authors.lastname: Schlageter
authors.forename: Christine
authors.initials: C
authors.lastname: Dosquet
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Kiladjian
authors.forename: Christine
authors.initials: C
authors.lastname: Chomienne
mesh_terms: D000369:Aged, 80 and over; D015897:Comorbidity; D004351:Drug Resistance; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000097:blood; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D020125:Mutation, Missense; D018962:Phlebotomy; D017354:Point Mutation; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications / Q000000981:diagnostic imaging; D011086:Polycythemia / Q000209:etiology*; D011087:Polycythemia Vera / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D014463:Ultrasonography
chemical_list: D004921:Erythropoietin; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D006918:Hydroxyurea